Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lysosomal sequestration of amine‐containing drugs: Analysis and therapeutic implications

Identifieur interne : 001B35 ( Main/Exploration ); précédent : 001B34; suivant : 001B36

Lysosomal sequestration of amine‐containing drugs: Analysis and therapeutic implications

Auteurs : Allyn M. Kaufmann [États-Unis] ; Jeffrey P. Krise [États-Unis]

Source :

RBID : ISTEX:FEEECDEACFAEFA0EE7D06FAB224AFB588646B515

English descriptors

Abstract

Amine‐containing drugs represent a very important class of therapeutic agents, with the majority of all drugs containing at least one basic nitrogen. For many decades, it has been known that weakly basic compounds can be sequestered into acidic organelles such as lysosomes. Some amines can achieve very high concentrations and induce a dramatic expansion (vacuolization) of the compartment. In the early 70s, Nobel laureate and discoverer of lysosomes, Christian de Duve et al. wrote an elegant commentary describing the theoretical basis for lysosomal sequestration of amines, referring to the process as pH‐partitioning and the substrates as lysosomotropics. Recently, a resurgence of interest in the intracellular distribution of drugs has occurred considering its therapeutic importance. Specifically, lysosomal sequestration of amines has received considerable attention for reasons including its involvement in drug resistance, inducement of phospholipidosis, and its influence on whole body distribution/pharmacokinetics. Moreover, the sequestration phenomenon has been recently exploited in the development of a novel drug targeting strategy. This review will focus on these occurrences/developments and conclude with a commentary on the expected impact that knowledge regarding the intracellular distribution of drugs will likely have on future drug development processes. © 2006 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 729–746, 2007

Url:
DOI: 10.1002/jps.20792


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lysosomal sequestration of amine‐containing drugs: Analysis and therapeutic implications</title>
<author>
<name sortKey="Kaufmann, Allyn M" sort="Kaufmann, Allyn M" uniqKey="Kaufmann A" first="Allyn M." last="Kaufmann">Allyn M. Kaufmann</name>
</author>
<author>
<name sortKey="Krise, Jeffrey P" sort="Krise, Jeffrey P" uniqKey="Krise J" first="Jeffrey P." last="Krise">Jeffrey P. Krise</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FEEECDEACFAEFA0EE7D06FAB224AFB588646B515</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/jps.20792</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7RXS8R87-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A07</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A07</idno>
<idno type="wicri:Area/Istex/Curation">001A07</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A18</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A18</idno>
<idno type="wicri:doubleKey">0022-3549:2007:Kaufmann A:lysosomal:sequestration:of</idno>
<idno type="wicri:Area/Main/Merge">001B46</idno>
<idno type="wicri:Area/Main/Curation">001B35</idno>
<idno type="wicri:Area/Main/Exploration">001B35</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Lysosomal sequestration of amine‐containing drugs: Analysis and therapeutic implications</title>
<author>
<name sortKey="Kaufmann, Allyn M" sort="Kaufmann, Allyn M" uniqKey="Kaufmann A" first="Allyn M." last="Kaufmann">Allyn M. Kaufmann</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Kansas</region>
</placeName>
<wicri:cityArea>Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Krise, Jeffrey P" sort="Krise, Jeffrey P" uniqKey="Krise J" first="Jeffrey P." last="Krise">Jeffrey P. Krise</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Kansas</region>
</placeName>
<wicri:cityArea>Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Kansas</region>
</placeName>
<wicri:cityArea>Correspondence address: Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Pharmaceutical Sciences</title>
<title level="j" type="alt">JOURNAL OF PHARMACEUTICAL SCIENCES</title>
<idno type="ISSN">0022-3549</idno>
<idno type="eISSN">1520-6017</idno>
<imprint>
<biblScope unit="vol">96</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="729">729</biblScope>
<biblScope unit="page" to="746">746</biblScope>
<biblScope unit="page-count">18</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-04">2007-04</date>
</imprint>
<idno type="ISSN">0022-3549</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-3549</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acidic</term>
<term>Acidic organelles</term>
<term>Amine</term>
<term>Anticancer agents</term>
<term>April</term>
<term>Assay</term>
<term>Basic compounds</term>
<term>Basic drugs</term>
<term>Basic inhibitors</term>
<term>Basic molecules</term>
<term>Bilayers</term>
<term>Biochim biophys acta</term>
<term>Biol</term>
<term>Cancer cells</term>
<term>Cell cytosol</term>
<term>Cell line</term>
<term>Cell lines</term>
<term>Cell types</term>
<term>Cellular distribution</term>
<term>Chem</term>
<term>Compound</term>
<term>Cytosol</term>
<term>Defective lysosomal</term>
<term>Dextran</term>
<term>Differential selectivity</term>
<term>Doxorubicin</term>
<term>Drug delivery</term>
<term>Duve</term>
<term>Duvvuri</term>
<term>Endocytic</term>
<term>Free base form</term>
<term>Human leukemic cell line</term>
<term>Important consideration</term>
<term>Inhibitor</term>
<term>Intracellular</term>
<term>Intracellular distribution</term>
<term>Isolation procedure</term>
<term>Kaufmann</term>
<term>Krise</term>
<term>Lipid</term>
<term>Lipid bilayers</term>
<term>Lysosomal</term>
<term>Lysosomal accumulation</term>
<term>Lysosomal lipid bilayer</term>
<term>Lysosomal lipid bilayers</term>
<term>Lysosomal lumen</term>
<term>Lysosomal membrane</term>
<term>Lysosomal membranes</term>
<term>Lysosomal sequestration</term>
<term>Lysosome</term>
<term>Lysosomotropic</term>
<term>Lysosomotropic agents</term>
<term>Mechanistic basis</term>
<term>Methodology</term>
<term>Mitochondrion</term>
<term>Molecule</term>
<term>Multidrug resistance</term>
<term>Neutral inhibitors</term>
<term>Normal cells</term>
<term>Novel drug</term>
<term>Organelle</term>
<term>Passive diffusion</term>
<term>Permeability</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical sciences</term>
<term>Pharmacol</term>
<term>Pharmacol toxicol</term>
<term>Physicochemical</term>
<term>Physicochemical properties</term>
<term>Plasma membrane</term>
<term>Proc natl acad</term>
<term>Psychotropic drugs</term>
<term>Selectivity</term>
<term>Sequestration</term>
<term>Subcellular</term>
<term>Uorescence</term>
<term>Uorescent</term>
<term>Uorescent compounds</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="fr">Amine‐containing drugs represent a very important class of therapeutic agents, with the majority of all drugs containing at least one basic nitrogen. For many decades, it has been known that weakly basic compounds can be sequestered into acidic organelles such as lysosomes. Some amines can achieve very high concentrations and induce a dramatic expansion (vacuolization) of the compartment. In the early 70s, Nobel laureate and discoverer of lysosomes, Christian de Duve et al. wrote an elegant commentary describing the theoretical basis for lysosomal sequestration of amines, referring to the process as pH‐partitioning and the substrates as lysosomotropics. Recently, a resurgence of interest in the intracellular distribution of drugs has occurred considering its therapeutic importance. Specifically, lysosomal sequestration of amines has received considerable attention for reasons including its involvement in drug resistance, inducement of phospholipidosis, and its influence on whole body distribution/pharmacokinetics. Moreover, the sequestration phenomenon has been recently exploited in the development of a novel drug targeting strategy. This review will focus on these occurrences/developments and conclude with a commentary on the expected impact that knowledge regarding the intracellular distribution of drugs will likely have on future drug development processes. © 2006 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 729–746, 2007</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Kansas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Kansas">
<name sortKey="Kaufmann, Allyn M" sort="Kaufmann, Allyn M" uniqKey="Kaufmann A" first="Allyn M." last="Kaufmann">Allyn M. Kaufmann</name>
</region>
<name sortKey="Krise, Jeffrey P" sort="Krise, Jeffrey P" uniqKey="Krise J" first="Jeffrey P." last="Krise">Jeffrey P. Krise</name>
<name sortKey="Krise, Jeffrey P" sort="Krise, Jeffrey P" uniqKey="Krise J" first="Jeffrey P." last="Krise">Jeffrey P. Krise</name>
<name sortKey="Krise, Jeffrey P" sort="Krise, Jeffrey P" uniqKey="Krise J" first="Jeffrey P." last="Krise">Jeffrey P. Krise</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B35 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B35 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FEEECDEACFAEFA0EE7D06FAB224AFB588646B515
   |texte=   Lysosomal sequestration of amine‐containing drugs: Analysis and therapeutic implications
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021